Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
-
ADMA Biologics Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
ADMA Biologics (ADMA) Prices 1.89M Common Stock Offering at $6.50/Share
-
ADMA Biologics Announces Pricing of Public Offering of Common Stock
-
Maxim Group Keeps ADMA Biologics (ADMA) at 'Buy' Following RI-002 BLA Submission; Sees Approval in Q316
-
ADMA Biologics Announces Closing of Public Offering of Common Stock and Exercise of Over-Allotment Option in Full
-
Adma Biologics (ADMA) Prices 1.23M Common Offering for Proceeds of $9.8M
-
ADMA Biologics Announces Pricing of Public Offering of Common Stock
-
ADMA Biologics Announces Pricing of Public Offering of Common Stock
-
ADMA Biologics (ADMA) PT Raised to $18 at Maxim Group
-
Maxim Group Starts ADMA Biologics (ADMA) at Buy